| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
08-26-2017, 02:10 AM
|
#1 | ||
|
|||
|
News Gatherer
Community Support Team
|
Medscape FDA Clears First Drug for Parkinson's Dyskinesia Medscape The US Food and Drug Administration (FDA) has approved amantadine extended-release capsules (Gocovri, Adamas Pharmaceuticals Inc) for treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without ... Adamas wins its first FDA OK, setting up market launch for a reformulated Parkinson's drugEndpoints News Adamas Pharma secures approval for Parkinson's dyskinesia drugReuters Adamas Pharma shares soar on Parkinson's dyskinesia drug approvalMarketWatch Benzinga -STAT -Neurology Advisor -GlobeNewswire all 54 news articles » More... |
||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Adamas Pharma shares soar on Parkinson's dyskinesia drug approval - MarketWatch | Parkinson's News | |||
| Diabetes Drug May Slow Parkinson's Disease - Medscape | Parkinson's News | |||
| Drug reduces dyskinesia, 'off' times in Parkinson's patients - Reuters | Parkinson's News | |||
| Hepatitis B and C Linked to Parkinson's - Medscape | Parkinson's News | |||
| Managing Parkinson's Disease During Ramadan - Medscape | Parkinson's News | |||
FDA Clears First Drug for Parkinson's Dyskinesia - Medscape
Linear Mode
